Tag: z.doj
Nationwide Lawsuit Against AmerisourceBergen Corp. and Subsidiaries: Controlled Substances Act Violations
In a civil complaint filed today, the Department of Justice alleges that AmerisourceBergen Corporation and two of its subsidiaries, AmerisourceBergen Drug Corporation and Integrated Commercialization Solutions, LLC (together “AmerisourceBergen”), collectively one of the country’s largest wholesale pharmaceutical distributors, violated federal law in connection with the distribution of controlled substances to pharmacies and other customers across the country, contributing to the prescription opioid epidemic. The complaint alleges that this unlawful conduct resulted in at least hundreds of thousands of violations…
CytoDyn Inc: Two Biotech CEOs Charged in Securities Fraud Schemes #leronlimab
A federal grand jury in the District of Maryland returned an indictment that was unsealed today charging two men for their roles in schemes to defraud investors in CytoDyn Inc., a publicly traded biotechnology company (OTCQB: CYDY) based in Vancouver, Washington. According to court documents, Nader Pourhassan, 59, of Lake Oswego, Oregon, and Kazem Kazempour, 69, of Potomac, Maryland, allegedly engaged in a conspiracy to defraud investors through false and misleading representations and material omissions relating to CytoDyn’s development of…
Advanced Bionics LLC to Pay Over $12 Million for Alleged False Claims for Cochlear Implant Processors
Advanced Bionics LLC, a Valencia, California-based manufacturer of cochlear implant system devices, has agreed to pay more than $12 million to resolve allegations that it misled federal health care programs regarding the radio-frequency (RF) emissions generated by some of its cochlear implant processors. “The United States expects device manufacturers to provide accurate information when they claim that their devices meet certain tests or standards,” said Principal Deputy Assistant Attorney General Brian M. Boynton, head of the Department of Justice’s Civil…
Corporate and White-Collar Enforcement in 2023–24
As 2022 comes to a close, is it possible to predict a trend for corporate and white-collar enforcement by the U.S. Department of Justice in 2023? Yes: enforcement will increase in 2023, and it will increase yet more in 2024. Understanding the Department as a dispersed, human institution that responds to incentives explains why.
Honeywell UOP to Pay Over $160 Million to Resolve Foreign Bribery Investigations in U.S. and Brazil
According to the company’s admissions and court documents, between 2010 and 2014, Honeywell UOP conspired to offer an approximately $4 million bribe to a then-high-ranking executive of Petróleo Brasileiro S.A (Petrobras) in Brazil. Specifically, Honeywell UOP offered the bribe to secure improper advantages in order to obtain and retain business from Petrobras in connection with Honeywell UOP’s efforts to win an approximately $425 million contract from Petrobras to design and build an oil refinery called Premium.
January 6 committee expected to announce referral of multiple criminal charges against Trump to DOJ
The House select committee investigating January 6, 2021, is expected to announce it will refer at least three criminal charges against former President Donald Trump to the Justice Department, including insurrection, obstruction of an official proceeding and conspiracy to defraud the federal government, according to a source familiar with the matter. The committee’s final recommendations could include additional charges proposed for Trump, according to the source. The referral recommendations will be presented at a committee meeting on Monday and the…
Academy Mortgage Corporation to Pay $38.5 Million: False Claims Act Allegations Related to Mortgages Insured by Federal Housing Administration
Thrower alleged that from January 2008 through April 2017, Academy had an underwriting process that led employees to disregard FHA rules and falsely certify compliance with underwriting requirements. Thrower further alleged that, as a result of Academy’s knowingly deficient mortgage underwriting practices, the government paid insurance claims on loans improperly underwritten by Academy.
“Lenders that knowingly cause the government to guarantee loans that are materially deficient put both homeowners and the public fisc at risk,” said Principal Deputy Assistant Attorney General Brian M. Boynton, head of the Justice Department’s Civil Division. “The settlement announced today is a result of the relator’s efforts to develop this case in litigation and complements the department’s actions to prevent abuse of government programs designed to foster home ownership.”
Eight Men Indicted for Securities Fraud Scheme Orchestrated Through Twitter and Discord
A federal grand jury in the Southern District of Texas returned an indictment that was unsealed yesterday charging eight men with conspiracy to commit securities fraud for a long-running, social media-based “pump and dump” scheme. According to court documents, Edward Constantinescu, aka Constantin, 38, of Montgomery, Texas; Perry “PJ” Matlock, 38, of The Woodlands, Texas; John Rybarczyk, 32, of Spring, Texas; Gary Deel, 28, of Beverly Hills, California; Stefan Hrvatin, 35, of Miami, Florida; Tom Cooperman, 34, of Beverly Hills,…
DOJ Announces New Corporate Enforcement Strategy
On September 15, 2022, Deputy Attorney General Lisa Monaco announced updated guidelines for the U.S. Department of Justice’s (“DOJ”) corporate criminal enforcement in a speech at New York University Law School. Monaco previously announced in October 2021 that DOJ would take a tougher stance on white collar crime. Shortly thereafter, Monaco formed an advisory group to evaluate potential changes to existing DOJ policies to facilitate DOJ’s more aggressive approach. The advisory group solicited feedback from defense counsel, executives, compliance personnel,…
DOJ Opens Probe Into Falsified Data Allegations Against Cassava
Jul 27, 2022. The United States Department of Justice has opened an investigation into the Austin, Texas-based Cassava Sciences regarding allegations that the company falsified data to support Simufilam, its drug candidate for Alzheimer’s disease. The probe could swing both ways, leading to criminal charges or end with no resulting lawsuit. The probe, revealed in an exclusive report by Reuters, will be led by investigators experienced in determining whether or not entities have defrauded consumers, investors or government agencies, according…